User:dezamizumab082122

GSK2398852, now known as Dezamizumab, is a groundbreaking monoclonal antibody currently under therapeutic assessment for its capacity to block the phosphatase CD22, a crucial regulator of B-cell

https://antisapdezamizumab296322.mpeblog.com/76522591/dezamizumab-a-deep-investigation-into-gsk2398852-and-its-promise